Manufacturing channel feed – Endpoints News

The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Oncorus plots early-stage plant in Boston area as it walks I-O candidate through the clinic

5 years ago

Fast-expanding Shanghai Pharma breaks ground on $1.8B biotech park focused on next-gen R&D, antibody production

5 years ago

Amgen hands off rights to leprosy, tuberculosis med picked up as part of $13.4B Otezla deal

5 years ago

Twist Bioscience plots its 'factory of the future' in Oregon, seeks to expand synthetic DNA client base

5 years ago

Amid a busy year and new leadership, Lonza looks to build bioconjugates capacity with Swiss expansion set for 2022

5 years ago

FDA stiff arms Novartis in a surprise setback for their PCSK9 drug inclisiran

5 years ago

Taysha Gene Therapies looks to build on rapid IPO with $85M dev-manufacturing plant in North Carolina

5 years ago

Continuing rapid expansion, Thermo Fisher says it will add on plasmid DNA manufacturing site in California

5 years ago

Vectura leans into new role as inhalation CDMO post-asthma flop with plant expansion

5 years ago

Gottlieb op-ed: Manufacturers need to ramp up production of antibodies as 'Covid insurance policy'

5 years ago

Looking for an edge in vaccines, Thermo Fisher plots major expansions across global manufacturing sites in its portfolio

5 years ago

With plans to bring surufatinib stateside, Chi-Med vastly scales up manufacturing with new Chinese plant

5 years ago

Korea's Celltrion invests $453M into new manufacturing plant, research center

5 years ago

First page Previous page 77 78 7980